Winnipeg Free Press By: Kellen Taniguchi
Dr. Soheila Karimi at the University of Manitoba’s Brodie Centre.
Researchers at the University of Manitoba have discovered a protein that has the potential to be used in the treatment of multiple sclerosis and as a marker for early diagnosis of the disease.
Researchers at the University of Manitoba have discovered a protein that has the potential to be used in the treatment of multiple sclerosis and as a marker for early diagnosis of the disease.
The study shows a link between the decrease of the protein, Neuregulin-1 beta 1, and MS, says research published this week in the peer-reviewed neurology journal
Posted: Dec 14, 2020 5:23 PM CT | Last Updated: December 14, 2020
U of M researchers have found a potential Neuregulin-1 beta 1 protein treatment for MS that could balance out the immune system and slow disease progression.(CBC)
Researchers at the University of Manitoba have uncovered a potential treatment for multiple sclerosis (MS) that could also help predict if someone might develop the disease.
The new study, led by Hardeep Kataria (PhD) and published this week in the peer-reviewed neurology journal Brain, focuses on cell protein Neuregulin-1 beta 1. Researchers found a link between a decline in Neuregulin-1 beta 1 levels and the onset and progression of MS.